中国血液净化

中国血液净化 ›› 2024, Vol. 23 ›› Issue (09): 686-689.doi: 10.3969/j.issn.1671-4091.2024.09.011

• 综述 • 上一篇    下一篇

维持性血液透析患者肺动脉高压的研究进展

辜雅静    刘俪婷    姜 燕    苏朝江    陈 彦    刘宗旸   

  1. 550004 贵阳，1贵州医科大学临床医学院
    550003 贵阳，2贵州医科大学附属肿瘤医院肾内科
  • 收稿日期:2024-04-17 修回日期:2024-05-30 出版日期:2024-09-12 发布日期:2024-09-12
  • 通讯作者: 刘宗旸 E-mail:guyajing128@163.com
  • 基金资助:
    贵州省卫生健康委科学技术基金(gzwkj2022-325)；贵州省卫生健康委科学技术基金项目(gzwkj2023-143)

Research progresses in pulmonary hypertension in maintenance hemodialysis patients

GU Ya-jing, LIU Li-ting, JIANG Yan, SU Chao-jiang, CHEN Yan, LIU Zong-yang   

  1. School of Clinical Medicine, Guizhou Medical University, Guiyang 550004; 2Department of Nephrology, The Cancer Hospital Affiliated to Guizhou Medical University, Guiyang 550003, China
  • Received:2024-04-17 Revised:2024-05-30 Online:2024-09-12 Published:2024-09-12
  • Contact: 550003 贵阳，2贵州医科大学附属肿瘤医院肾内科 E-mail:guyajing128@163.com

PDF

19

摘要： 肺动脉高压是一种以肺血管阻力持续升高为特征的临床疾病，其在维持性血液透析患者中很常见，并与高死亡率相关，但其发病机制未明，临床症状隐匿。因此，本文就国内外关于维持性血液透析患者肺动脉高压的研究进展作一综述，为维持性血液透析患者的肺动脉高压提供早期诊断和治疗的依据。

关键词: 维持性血液透析, 肺动脉高压, 危险因素

Abstract: Pulmonary hypertension is a clinical disorder characterized by the continuing hyper-resistance of pulmonary vessels. Pulmonary hypertension is frequently encountered in maintenance hemodialysis (MHD) patients with a higher mortality rate. The mechanism of the disorder is yet unknown, and its clinical presentations are insidious. Here we summarize the recent progresses in pulmonary hypertension in MHD patients in China and foreign countries, so as to provide references for early diagnosis and management of pulmonary hypertension in MHD patients.

Key words: Maintenance hemodialysis, Pulmonary hypertension, Risk Factors

中图分类号: